Blog

CRISPR/Cas9 Treatment for Duchenne Muscular Dystrophy – Muscular Dystrophy News

CRISPR/Cas9 Treatment for Duchenne Muscular Dystrophy
Muscular Dystrophy News
The CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) method for genome editing is a powerful, new medical technology with many applications in biomedical research, including the potential to treat human genetic diseases, such …

and more »

2017-01-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.